ISoP MCS SIG and SxP SIG will be hosting free webinars in March and April. March 22, 2023 at 11 am EST Leveraging IPF QSP Modeling and Simulated Patients to Build a Model of SSc-ILD March 28, 2023 at 10 am EST A Gentle Introduction to Optimal Design for Pharmacometric Models April 26, 2023 at…
ISoP is pleased to announce Vijay Ivaturi, Ph.D., as the 2023 President-Elect. Dr. Ivaturi will serve in this role for a one-year term and then will assume the ISoP presidency in January 2024, for a two-year term. As President-Elect, Dr. Ivaturi will oversee the development of ISoP’s three-year strategic plan to advance ISoP’s mission for the promotion and advancement of the discipline…
We are excited to spotlight Michelle Johnson and her purpose driven leadership style as the CEO of MetrumRG. Learn about Michelle’s passion for her work and how she dreamt of being a stunt double here.
We’re kicking off summer early so you can connect with co-workers and colleagues at our In Person Networking Event hosted by local ISoP groups. Join three of our local groups on Thursday, June 2nd beginning at 5 pm ET, for a fun night of networking and catching up. The event locations are as follows: In…
Our series of Members Meetings to share the Board’s strategic vision for the society as well as discuss ISoP’s transition to a non-profit organization start this Thursday, May 19th. The ISoP Board has approved a plan to transition the society to a tax-exempt organization, and we are asking for you to support this plan. Register…
For all the latest ISoP news, you can read the newsletter here.
Check out the lastest news from the QSP SIG here.
Get to know ISoP’s new Executive Team and Board members in this special election newsletter. You can read and/or download the newsletter here.
The ISoP Insider Fall Newsletter is here. New look, same great information and insights into all things ISoP. You can read and/or download the newsletter here.
The ISoP Clinical Pharmacometrics Special Interest Group in collaboration with ACCP recently released a white paper highlighting the need for greater exposure-based drug labeling to reduce the widespread and risky practice of off-label dosing. Such a pharmacometric approach to prescribing can improve the care and treatment of individual patients. You can read the whitepaper by clicking…